{"nct_id":"NCT04609566","title":"Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2021-01-26","start_date_type":"ACTUAL","primary_completion_date":"2029-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2029-12-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["PFE"]}